Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
eBay
EBAY
US Stock MarketDetailed Quotes
CHGCY Chugai Pharmaceutical (ADR)
- 28.320
- +0.130+0.46%
15min DelayClose Apr 29 16:00 ET
93.20BMarket Cap32.37P/E (TTM)
29.290High27.100Low77.50KVolume27.700Open28.190Pre Close2.20MTurnover0.00%Turnover Ratio34.29P/E (Static)3.29BShares30.84052wk High7.03P/B93.20BFloat Cap14.52052wk Low0.35Dividend TTM3.29BShs Float30.840Historical High1.23%Div YieldTTM7.77%Amplitude10.990Historical Low28.329Avg Price1Lot Size
About Chugai Pharmaceutical (ADR) Company
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
Company Profile
SymbolCHGCY
Company NameChugai Pharmaceutical (ADR)
Founded1925
CEODr. Osamu Okuda
MarketPink Market
Employees7432
Fiscal Year Ends12-31
AddressNihonbashi Mitsui Tower, 15/F,2-1-1 Nihonbashi-Muromachi,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8324
Phone81-3-3281-6611
Company Executives
- Name
- Position
- Salary
- Dr. Osamu Okuda
- President, Director and Chief Executive Officer
- --
- Iwaaki Taniguchi
- Director, Senior Vice President, Head, Finance Supervisory and Head, Finance and Accounting Dept.
- --
- Hitoshi Iikura
- Director, Vice President and Head, Translational Research
- --
- Teresa A. Graham
- Director
- --
- Dr. James H. Sabry,M.D.,PhD
- Director
- --
- Dr. Christoph Franz
- Director
- --
- Mariko Y. Momoi
- Independent Director
- --
- Hideo Teramoto
- Independent Director
- --
- Fumio Tateishi
- Independent Director
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now